Ana Izquierdo Gil

Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru

Claudio F. Lanata, Teresa Andrade, Ana Izquierdo Gil et al. · Vaccine · 2012 · 72 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP

Laura Solforosi, Harmjan Kuipers, Mandy Jongeneelen et al. · The Journal of Experimental Medicine · 2021 · 70 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease

Joan E. M. van der Lubbe, Sietske K. Rosendahl Huber, Aneesh Vijayan et al. · npj Vaccines · 2021 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety and Immunogenicity of an Investigational Fully Liquid Hexavalent DTaP-IPV-Hep B-PRP-T Vaccine at Two, Four and Six Months of Age Compared With Licensed Vaccines in Latin America

M. Macías, Claudio F. Lanata, Betzana Zambrano et al. · The Pediatric Infectious Disease Journal · 2012 · 36 citations

Veterinary Medicine, Infectious Diseases, Pediatrics +17

Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults

Ana Izquierdo Gil · Vaccine · 1996 · 34 citations

Veterinary Medicine, Immunology, Infectious Diseases +13